- GlobeNewswire•19 days ago
NORTHVALE, N.J., Aug. 10, 2016-- Elite Pharmaceuticals, Inc. today announced that it has filed an Abbreviated New Drug Application with the US Food and Drug Administration for a generic version of Percocet ...
- GlobeNewswire•20 days agoElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2017 and Provides Conference Call Information
NORTHVALE, N.J., Aug. 09, 2016-- Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, announced results for the three months ended ...
- Capital Cube•last month
Click here to see latest analysisElite Pharmaceuticals, Inc. reports financial results for the year ended March 31, 2016.HighlightsGross margins widened from 27.61% to 58.80% compared to the same period last year, operating (EBITDA) margins now -61.22% from -316.83%.Change in operating cash flow of 81.69% compared to same period last year is about the same as […] (Read more...) The post Elite Pharmaceuticals, Inc. :ELTP-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 appeared first on CapitalCube.
Elite Pharmaceuticals, Inc. (ELTP)
OTC BB - OTC BB Delayed Price. Currency in USD
|Day's Range||0.16 - 0.17|
|52wk Range||0.11 - 0.44|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-5.23|
|Avg Vol (3m)||2,196,255|
|Dividend & Yield||N/A (N/A)|